Categories Earnings, Health Care

Abiomed, Inc. (NASDAQ: ABMD): Q3 2020 Earnings Snapshot

— Medical device maker Abiomed, Inc. (NASDAQ: ABMD) reported net income of $69.2 million or $1.51 per share for the third quarter of 2020, vs. $1.09 per share expected.

Abiomed, Inc. (NASDAQ: ABMD): Q3 2020 Earnings Snapshot

— Revenue increased 10% annually to $221.6 million during the three-month period, vs. $226.99 million expected

— US revenue rose 8% to $185.6 million, while overseas revenue moved up 29% to $36 million

— Third-quarter gross margin was 82%, down from 83% reported a year earlier

— Announced initiation of the ST-Elevation Myocardial Infarction Door-to-Unloading Pivotal Randomized Controlled Trial during the quarter

— Expects full-year 2020 revenue to be in the range of $846 million to $877 million, up 10% to 14% respectively

— Confirms full-year 2020 unadjusted operating margin guidance in the range of 28% to 30%

Listen to publicly listed companies’ earnings conference calls along with the edited closed caption text

Most Popular

Kroger (KR) looks set to start 2023 with new vigor. Is the stock a buy?

The retail environment has witnessed many changes in customers’ shopping behavior lately, especially after the COVID outbreak. With inflation putting pressure on personal finances, there appears to be a new

Dollar General (DG): Five takeaways from the discount store’s Q3 earnings report

Shares of Dollar General Corporation (NYSE: DG) were up over 2% on Friday, a day after the company delivered mixed results for the third quarter of 2022 and lowered its

Salesforce stock hit by weak guidance, co-CEO’s exit. What next?

For technology stocks, 2022 has been a challenging year, with companies losing significant market value amid prolonged stock selloff. In that respect, Salesforce, Inc. (NYSE: CRM) is among the worst-affected

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top